JANUS NEW

Company

Perspective Therapeutics, Inc.

Filed

November 14, 2024

Accession Number

0001274173-24-000094

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →